✦ LIBER ✦
Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose
✍ Scribed by Joseph F. Contrera; Edwin J. Matthews; Naomi L. Kruhlak; R. Daniel Benz
- Book ID
- 116991729
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 491 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0273-2300
No coin nor oath required. For personal study only.